Dr. Amit Kumar Bhise, MD

Dr. Bhise practices at Swedish Medical Center -First Hill in Seattle, Washington.

Dr. Bhise's NPI, 1396977948, was assigned on August 17, 2009. Dr. Bhise holds Washington license MD61394784.

Dr. Bhise's primary practice is Swedish Medical Center -First Hill, at 747 Broadway, Seattle, WA 98122 in King County. The practice phone is (206) 386-6000.

Dr. Bhise's primary practice is Swedish Medical Center -First Hill in Seattle, Washington. Dr. Bhise is also affiliated with Swedish First Hill Campus. The medical group on file is Swedish Health Services. Dmand AI also links Dr. Bhise to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bhise practices, 3 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Bhise's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Bhise is licensed in Washington.

CMS data shows 611 Medicare services from Dr. Bhise across 4 procedure codes in 2024, for 187 Medicare patients. Medicare paid $46,153 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 187 Medicare patients who saw Dr. Bhise in 2024. The largest group is 75 to 84, with 72 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bhise's median patient age at 74, with 49% women.

In 2024, Dr. Bhise wrote 210 Medicare Part D claims for 83 patients. 88% of them were for generic drugs. CMS names the drug for 43 of them, across 3 drugs with 11 or more claims each, at $297 in total drug cost. In 2023, CMS named 76 claims across 6 drugs.

Dr. Bhise accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 41 general payments to Dr. Bhise from 10 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $146.